Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-03-14
2010-06-22
Chen, Shin-Lin (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S002600, C536S023100, C530S350000, C435S320100, C435S455000
Reexamination Certificate
active
07741302
ABSTRACT:
A transposase encoded by the Tol2 element; a polynucleotide encoding the same; a method of modifying the gene structure of a cell (preferably a vertebrate cell) by using the above protein; a method of modifying the function of a cell by modifying the gene structure thereof; and a cell having been modified in function by these methods. Also the structure of a cis element necessary in gene transfer is clarified and presented.
REFERENCES:
patent: 7034115 (2006-04-01), Kawakami
patent: 2006/0211116 (2006-09-01), Kawakami
patent: 2006/0212958 (2006-09-01), Kawakami
Kawakami et al., Nov. 1999, GenEmbl Accession No. AB032244, pp. 1-3.
SPTREMBL Accession Nos. Q98968, 98969, 98970, and 98971, 1997, pp. 3-4.
Ivics et al., 1997, Cell, vol. 91, p. 501-510.
Kawakami et al., 2000, UniProt, Accession No. Q9PVN3, computer printout, p. 2-3.
Atkinson et al., 1993, PNAS, vol. 90, pp. 9693-9697.
K. Kawakami et al.,Gene, 240: 239-244 (1999).
K. Kawakami et al.,Gene, 225: 17-22 (1998).
A. Koga et al.,Genbank, Acc. No. D84375 (1999).
A. Koga et al.,FEBS Letters, 461: 295-298 (1999).
A Koga et al.,Nature, 383: 30 (1996).
G. Luo,Proc. Natl. Acad. Sci. USA, 95: 10769-10773 (1998).
L. Zhang et al.,Nucleic Acids Research, 26 (16): 3687-3693 (1998).
A. Sherman et al,Nature Biotechnology, 16:1050-1053 (1998).
Z. Li et al.,Somatic Cell and Molecular Genetics, 24(6): 363-369 (1998).
E. Rubin et al,Proc. Natl. Acad. Sci USA, 96: 1645-1650 (1999).
K. Kawakami et al.,Gene, 240: 239-244 (1999), Databse accession No. AB032244 (abstract only).
A. Koga et al.,Nature, 383: 30-30 (1996), Database accession No. Q98969 (abstract only).
Izsvak et al.,Biochemistry&Cell Biology, 75: 507-523 (1997).
GenEmbl Accession No. AB032244, Nov. 26, 1999, pp. 1-3.
SPTREMBL Accession Nos. Q98968, 98969, 98970, 98971, 1997, pp. 3-4.
Rudinger, 1976, Peptide Hormones, Parsons, University Park Press, Baltimore. p. 1-7.
Kaye et al., 1990, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 6922-6926.
Skolnick et al., 2000, Trends in Biotech, vol. 18, pp. 34-39.
De Lorenzo, Victor, “Genetic Engineering Strategies for Environmental Applications,” Current Opinion in Biotechnology, 3(3): 227-231 (1992).
Lewin, B., “Genes VI”, Chapter 18, p. 564 (Oxford University Press 1997) (excerpt).
Lander, E.S., et al., “Initial sequencing and analysis of the human genome”, Nature, 409(6822):860-921 (2001) (excerpt).
Ivics, Z., et al., “Molecular Reconstruction of Sleeping Beauty, a Tc1-like Transposon from Fish, and Its Transposition in Human Cells”, Cell, vol. 91, 501-510 (1997) (excerpt).
Kunze et al., “Transcription of transposable elementActivator(Ac) ofZea maysL.,” The EMBO Journal, vol. 6, No. 6, pp. 1555-1563 (1987).
Izsvak et al., “Short Inverted-Repeat Transposable Elements in Teleost Fish and Implications for a Mechanism of Their Amplification,” Journal of Molecular Evolution, vol. 48, pp. 13-21, (Jan. 1999).
Chen Shin-Lin
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Japan Science and Technology Agency
Russett Mark D.
LandOfFree
Transposase and method of gene modification does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transposase and method of gene modification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transposase and method of gene modification will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4247746